Hillary Clinton takes aim at increases in drug prices
The recent controversy over EpiPen price hikes has renewed interest in what, if anything, policymakers can do to help consumers deal with increases in drug prices. To her credit, Hillary Clinton unveiled a new proposal late last week about a larger governmental role. Slate did a nice job summarizing the presidential candidate’s plan:
As president, Clinton would create a task force of regulators with the power to decide whether price increases on old, essential medicines and devices were reasonable given product improvements and the amount of competition in the market. If not, the task force would have the power to mete out punishments to companies that were trying to profiteer, potentially with fines.